本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ProQR Therapeutics N.V.

2.40
+0.05002.13%
盘后2.400.00000.00%18:18 EDT
成交量:16.17万
成交额:38.61万
市值:2.53亿
市盈率:-6.60
高:2.46
开:2.35
低:2.33
收:2.35
数据加载中...
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/24

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals